Home › Drugs A to Z › E › Em › Emtricitabine/... Pregnancy Warnings
Print Save or Share

Emtricitabine / tenofovir Pregnancy and Breastfeeding Warnings

Emtricitabine / tenofovir is also known as: AccessPak for HIV PEP Basic, Truvada

Overview

If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Emtricitabine/Tenofovir while you are pregnant. It is not known if Emtricitabine/Tenofovir is found in breast milk. Mothers infected with HIV should not breast-feed. There is a risk of passing the HIV infection or Emtricitabine/Tenofovir to the baby. Do not breast-feed while taking Emtricitabine/Tenofovir.

Emtricitabine / tenofovir Pregnancy Warnings

To monitor fetal outcomes of pregnant women exposed to emtricitabine-tenofovir, an Antiretroviral Pregnancy Registry has been established. Healthcare providers are encouraged to register patients by calling 1-800-258-4263 (USA).

Emtricitabine-tenofovir has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of embryofetal toxicity or teratogenicity. There are no controlled data in human pregnancy. Emtricitabine-tenofovir should be used during pregnancy only if clearly needed.

Emtricitabine / tenofovir Breastfeeding Warnings

There are no data on the excretion of emtricitabine or tenofovir into human milk. Tenofovir is excreted into the milk of lactating rats. HIV-infected mothers should not breast-feed their infants due to the risk of transmission of HIV via breast milk.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

(web5)